FOLLOW US

In a dramatic legal showdown that underscores the high-stakes war over product liability and federal oversight, Monsanto, a unit of Bayer AG, failed to overturn a $175 million jury verdict awarded to a Pennsylvania man who linked his cancer to the controversial weedkiller Roundup. The Pennsylvania Superior Court ruled Thursday that the jury’s award to Ernest Caranci and his wife was both justifiable and constitutionally sound.

Court Dismisses Monsanto’s Federal Preemption Argument

The verdict strikes a decisive blow against Monsanto’s long-standing legal strategy: arguing that state-level “failure to warn” claims should be preempted by federal law under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA).

Monsanto leaned heavily on the Third Circuit’s 2023 ruling in Schaffner v. Monsanto Corp., which found such claims federally preempted. But the Superior Court flatly rejected that interpretation, asserting that Pennsylvania's laws align with FIFRA—not conflict with it.

“FIFRA requires manufacturers to include label warnings that are ‘adequate to protect health and the environment,’” wrote Judge Alice Beck Dubow. “Pennsylvania law doesn’t impose any stricter requirements—just parallel ones.”

This nuanced legal distinction could have far-reaching consequences, as it offers a judicial green light for other plaintiffs in Pennsylvania—and potentially beyond—to bring similar claims without running afoul of federal regulation.

$175 Million Verdict Called ‘Fair and Proportional’

Monsanto had also contended that the jury award to Caranci—who developed cancer after years of Roundup use—was excessive and legally unsound. But the court saw no reason to disturb the jury’s judgment.

While Monsanto expressed deep dissatisfaction with the decision and hinted at potential further appeals, the Superior Court's opinion delivers a firm message: corporate responsibility under state law can coexist with federal pesticide regulations.

A Monsanto spokesperson said the company is “considering its legal options,” maintaining that federal preemption should have invalidated the Caranci claim and others like it.

Legal Landscape Shifting for Roundup Lawsuits

This ruling adds fuel to the already raging legal fire Monsanto faces. Thousands of Roundup-related lawsuits are pending across the country, many hinging on the same failure-to-warn argument. The Pennsylvania court’s refusal to follow the Third Circuit’s path could create a patchwork of rulings and appeals across jurisdictions.

As the dust settles in this latest courtroom battle, one thing is clear: Monsanto’s legal war over Roundup is far from over, and state courts may yet prove to be formidable arenas where jury power and regulatory interpretation collide.

The Caranci case now returns to the lower court for further proceedings, but with a $175 million tailwind that suggests Monsanto's legal turbulence is just beginning.